PharmaBoardroom

Michael Gorenstein, CEO, The Cronos Group, Canada

“If you are trying to be everything to everybody, you end up being nothing to no one”—Michael Gorenstein, CEO of The Cronos Group talks to…

Interview: Florian Ibe – Managing Director, Bayer Portugal

Florian Ibe, managing director at Bayer Portugal, discusses market access hurdles, as well as Portugal’s expertise in scientific and clinical…

Interview: Paulo Climaco Lilaia – President, APOGEN,…

Paulo Lilaia, president of the board of APOGEN and CEO of Generis, highlights the need for generics in the healthcare system and the government’s…

Humberto Arnés – Director General, Farmaindustria, Spain

Humberto Arnés, director general at Farmaindustria, Spain’s leading pharmaceutical industry association, discusses the dynamics of the Spanish…

Interview: Ana Teresa Lehmann – Secretary of State for…

The Portuguese secretary of state for industry invites readers to discover the vibrant tech landscape in Portugal. Ana Teresa Lehmann unravels the…

Interview: Grace Zhou – Dean, Shenzhen International…

Dr. Grace Zhou, dean of SIIBR, discusses the Institute’s priorities, the benefits of being located in Shenzhen and the city’s potential as a…

Interview: Paul Apap Bologna – Managing Director,…

Paul Apap Bologna, managing director at Associated Drug Company (ADC), introduces his family company, focused on distributing high-quality innovative…

Interview: Claude A. Farrugia – Chairman, Pharmaceutical…

Prof. Claude A. Farrugia of the Malta Chamber of Commerce, Enterprise and Industry documents the main trends in the manufacturing industry of Malta…

Interview: Tang Dajie – Founder and CEO, Triwise Capital,…

Dr. Tang Dajie, founder and CEO of investment vehicle Triwise Capital, discusses the numerous investment opportunities in Shenzhen’s life sciences…

Interview: Ion Arocena – CEO, ASEBIO, Spain

Ion Arocena, CEO of ASEBIO, Spain’s biotech association, discusses the significant efforts that Spain has made in turning cutting-edge research into…

Mike Thompson – Chief Executive, ABPI, UK

Mike Thompson, chief executive of the Association of the British Pharmaceutical Industry (ABPI) reveals his staunch faith in the British health…

Takeda/Shire Deal to Spark Pharma M&A Boom?

With the USD 62 billion deal from Japan’s Takeda Pharmaceutical to buy Irish firm Shire finally agreed after months of wrangling, we asked…

Tagged with